MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer
Clinical trial NCT04078269 · COMPLETED
Trial details
- NCT number
- NCT04078269
- Sponsor
- University Hospital, Ghent
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2024-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.